ASX - Delayed Quote AUD
Nyrada Inc. (NYR.AX)
At close: October 23 at 4:10 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Expense
4,794.2470
4,794.2470
9,360.4140
5,065.8490
5,873.6590
--
Operating Income
-4,794.2470
-4,794.2470
-9,360.4140
-5,065.8490
-5,873.6590
--
Net Non Operating Interest Income Expense
161.0140
161.0140
148.8170
12.4440
-1.6160
--
Other Income Expense
3,241.9240
3,241.9240
1,429.9050
1,093.7440
2,336.0220
--
Pretax Income
-1,391.3090
-1,391.3090
-7,781.6920
-3,959.6610
-3,539.2530
--
Net Income Common Stockholders
-1,391.3090
-1,391.3090
-7,781.6920
-3,959.6610
-3,539.2530
--
Basic EPS
-0.01
--
-0.05
-0.03
-0.03
-0.09
Diluted EPS
-0.01
--
-0.05
-0.03
-0.03
-0.09
Basic Average Shares
163,006.5080
--
156,008.7000
156,008.7000
116,743.7480
60,911.0380
Diluted Average Shares
163,006.5080
--
156,008.7000
156,008.7000
116,743.7480
60,911.0380
Net Income from Continuing & Discontinued Operation
-1,391.3090
-1,391.3090
-7,781.6920
-3,959.6610
-3,539.2530
--
Normalized Income
-1,391.3090
-1,391.3090
-7,781.6920
-3,959.6610
-3,539.2530
--
Interest Income
161.0140
161.0140
148.8170
13.8300
3.9890
--
Interest Expense
1.3860
--
--
1.3860
5.6050
140.3550
Net Interest Income
161.0140
161.0140
148.8170
12.4440
-1.6160
--
EBIT
-4,794.2470
-4,794.2470
-9,360.4140
-3,958.2750
-3,533.6480
--
EBITDA
-4,789.0640
-4,789.0640
-9,353.8800
-3,953.5410
-3,531.8370
--
Reconciled Depreciation
5.1830
5.1830
6.5340
4.7340
1.8110
--
Net Income from Continuing Operation Net Minority Interest
-1,391.3090
-1,391.3090
-7,781.6920
-3,959.6610
-3,539.2530
--
Normalized EBITDA
-4,789.0640
-4,789.0640
-9,353.8800
-3,953.5410
-3,531.8370
--
6/30/2020 - 1/15/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOX.AX Noxopharm Limited
0.1400
+7.69%
DXB.AX Dimerix Limited
0.4200
+2.44%
IMU.AX Imugene Limited
0.0490
0.00%
MSB.AX Mesoblast Limited
1.2650
-1.94%
EFTR eFFECTOR Therapeutics, Inc.
0.0001
0.00%
TLX.AX Telix Pharmaceuticals Limited
20.90
-2.61%
NRXP NRx Pharmaceuticals, Inc.
1.2100
0.00%
NVO Novo Nordisk A/S
113.38
-0.47%